Phosphodiesterase 4D7 as prostate cancer marker

作者: David James Peter Henderson , Ralf Hoffmann , Miles Douglas Houslay

DOI:

关键词:

摘要: The present invention relates to phosphodiesterase 4D7 (PDE4D7) for use as a marker prostate cancer, and the of PDE4D7 diagnosing, detecting, monitoring or prognosticating cancer progression cancer. also composition corresponding method immunoassay, hormone-resistant vs. hormone-sensitive data acquisition, an immunoassay identifying individual eligibility therapy, stratifying cohort individuals with disease, well pharmaceutical comprising compound directly stimulating modulating activity PDE4D7, indirectly protein biologically active equivalent thereof, nucleic acid encoding expressing miRNA inhibitor specific miRNAs, demethylation agent and/or displacement factor.

参考文章(60)
L G Gomella, J G Moreno, M Monne, C M Croce, R Fischer, P Vihko, S G Mulholland, Detection of hematogenous micrometastasis in patients with prostate cancer Cancer Research. ,vol. 52, pp. 6110- 6112 ,(1992)
Robert J. Chambers, Thomas V. Magee, Anthony Marfat, Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes ,(2001)
Axel J Unterbeck, Daguang Wang, Vivo Michael De, Xiaonen Xin, Christopher J Leonard, Cyclic amp phosphodiesterase 4d7 isoforms and methods of use ,(2002)
Paolo Renzi, Luc Paquet, Helene D'anjou, Oligonucleotides affecting expression of phosphodiesterases ,(2007)
Shiv Srivastava, Judd W. Moul, Linda L. Xu, Androgen-regulated PMEPA1 gene and polypeptides ,(2006)
Alexander L. Ruchelman, George W. Muller, Isoindoline compounds and methods of their use ,(2012)
Miles D Houslay, PDE4 cAMP-specific phosphodiesterases. Progress in Nucleic Acid Research and Molecular Biology. ,vol. 69, pp. 249- 315 ,(2001) , 10.1016/S0079-6603(01)69049-4
David Gray Streeter, Douglas A. Fisher, Douglas H. Gooding, Cyclic gmp phosphodiesterase ,(1998)
David James Peter Henderson, Ralf Hoffmann, Miles Douglas Houslay, Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer ,(2010)